Claire Blesing

Swindon, ENG, GB 
Swindon, ENG, GB 

Overview

Claire Blesing practices practicing medicine in Swindon, United Kingdom.

Her clinical expertise encompasses Neurofibromatosis Type 2 (NF2), Neurofibromatosis, Schwannoma, and Acoustic Neuroma.

She is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Swindon, ENG, United Kingdom
Other Locations
Oxford, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Randomised, Multicentre Open-label Study of Active Symptom Control (ASC) Alone or ASC With Oxaliplatin/ 5F-U Chemotherapy for Patients With Locally Advanced/ Metastatic Biliary Tract Cancers Previously Treated With Cisplatin/ Gemcitabine Chemotherapy.
A Phase III, Randomised, Multicentre Open-label Study of Active Symptom Control (ASC) Alone or ASC With Oxaliplatin/ 5F-U Chemotherapy for Patients With Locally Advanced/ Metastatic Biliary Tract Cancers Previously Treated With Cisplatin/ Gemcitabine Chemotherapy.
Enrollment Status: Completed
Publish Date: January 28, 2020
Intervention Type: Other, Drug
Study Phase: Phase 3

8 Total Publications

Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit.
Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: September 11, 2016

Frequently Asked Questions about Claire Blesing

Is Claire Blesing a top-rated expert for Neurofibromatosis Type 2 (NF2)?

MediFind is an objective health platform that identifies experts based on real-world data. Claire Blesing is classified as an Experienced expert for Neurofibromatosis Type 2 (NF2), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Claire Blesing participate in research or clinical trials?

Yes. Claire Blesing has published 8 articles and abstracts on conditions like Neurofibromatosis Type 2 (NF2). You can view a list of Claire Blesing's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Blesing's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile